Catalyst Event
Neuromeka Co Ltd (348340) · Other
From Akros SCHK HK-Korea Humanoid Robotics Index (ASHKHRB)
4/24/2026, 12:00:00 AM
Announcement of a plan to raise KRW 150 billion through a rights offering on April 24, 2026; medium importance due to expected impact on capital structure and stock supply, scheduled.
Korean Translation
2026년 4월 24일 1500억원 규모 유상증자 계획 발표일이며, 자금 조달 및 유통 물량 변화에 따른 중간 수준의 중요도가 예상됨.
Related Recent Events
Neuromeka Co Ltd (348340) · Trading Issue
Confirmed corporate action: Neuromeka Co., Ltd. approved a 0.5-for-1 bonus issue (767,2130 new common shares) tied to its April 24, 2026 capital-raising package, with bonus issue record date August 3, 2026 and listing date August 25, 2026.
7/31/2026, 12:00:00 AM
Neuromeka Co Ltd (348340) · Trading Issue
Ex-rights date for a shareholder-allocated rights offering of approx. KRW 150 billion on June 12, 2026 (record date June 15, listing August 14); high importance due to significant share dilution, scheduled.
6/12/2026, 12:00:00 AM
CLOBOT Co Ltd (466100) · Trading Issue
Ex-rights date for a rights offering of 5,494,500 new shares at an estimated price of KRW 36,400 per share on 2026-06-08; high importance expected due to share dilution, scheduled.
6/8/2026, 12:00:00 AM
Fortior Technology Shenzhen Co Ltd (1304) · Other
The ex-dividend date for the 2025 final dividend of RMB 0.78 per share on 2026-06-03, following the 2026-03-27 proposal and 2026-05-20 AGM approval. Medium impact is estimated based on the dividend yield scheduled.
6/3/2026, 12:00:00 AM
Neuromeka Co Ltd (348340) · Earnings Release
Next earnings release on May 22, 2026; low importance based on typical market reaction to routine financial reporting, scheduled.
5/22/2026, 12:00:00 AM
AAC Technologies Holdings Inc (2018) · Other
The Annual General Meeting (AGM) is scheduled for May 21, 2026, to vote on the 2025 financial statements and the proposed final dividend; Low importance estimated as a routine event likely to result in a price impact of at least 1% scheduled
5/21/2026, 12:00:00 AM